Go to the Indico Home Page Oldest event Older event Up to category Newer event Newest event
  • Indico style
  • Indico style - inline minutes
  • Indico style - numbered
  • Indico style - numbered + minutes
  • Indico Weeks View
    • Switch to the management area of this event
    Login

    User Meeting 2018

    22–23 Nov 2018
    Australian Synchrotron
    Australia/Melbourne timezone
    Registrations & Abstracts have closed

    Bettina Richen, Events

    Session

    Parallel Session 8

    22 Nov 2018, 15:45

    Conveners

    Parallel Session 8: Radiotherapy

    • Daniel Hausermann (Australian Synchrotron)

    Presentation materials

    There are no materials yet.

    1. 77. Preparations for the first veterinary trials of synchrotron radiation therapy
      Dr Jeffrey CROSBIE (RMIT University)
      22/11/2018, 15:45
      Radiotherapy
      Oral

      The aim of our research is to undertake the first large animal trial of Microbeam Radiation Therapy (MRT) at the Australian Synchrotron to treat spontaneous cancers. The Imaging and Medical Beamline (IMBL) at the Australian Synchrotron is one of only four facilities in the world expressly designed to enable the clinical application of synchrotron radiotherapy for cancer patients. There are new...

      Go to contribution page
    2. 81. High resolution fibre-optic dosimetry: towards a MRT quality assurance device
      James Archer (University of Wollongong)
      22/11/2018, 16:15
      Radiotherapy
      Oral

      Synchrotron microbeam radiation therapy (MRT) is a novel external beam therapy under investigation for its application in the treatment of brain tumours. Key characteristics of these x-ray microbeams is their high flux, high spatial fractionation and large dose rates. For clinical quality assurance, the dose rate in the microbeams (peaks) and between them (valleys) must be measured accurately....

      Go to contribution page
    3. 24. Identifying optimal clinical scenarios for synchrotron microbeam radiation therapy
      Lloyd Smyth (University of Melbourne, ICON Cancer Centre)
      22/11/2018, 16:30
      Radiotherapy
      Oral

      Background: Synchrotron Microbeam Radiation Therapy (MRT) is a pre-clinical modality characterised by a periodically alternating peak-valley dose-distribution. Dosimetry studies using clinical datasets have not yet been conducted. Our aim was to identify optimal settings for a future Phase I trial from a range of clinical scenarios refractory to standard treatments.

      Materials and methods:...

      Go to contribution page
    Building timetable...